Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.75 |
| ▸ | APP | P05067 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.62 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2872287 | 0.97 | SLC2A1 (0.72) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL10023997 | 0.93 | SLC2A1 (0.67) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL11714214 | 0.93 | APP (0.71) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL10933094 | 0.93 | SLC2A1 (0.67) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL9479718 | 0.93 | SLC2A1 (0.67) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL23532435 | 0.87 | SLC2A1 (0.66) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL5981957 | 0.87 | MAPK1 (0.61) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL3223775 | 0.87 | MAPT (0.71) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL11145489 | 0.87 | SLC2A1 (0.60) | SLC2A1APPMAPTALDH1A1HSD17B10 | |
| SCHEMBL6368607 | 0.87 | MAOB (0.66) | SLC2A1APPMAPTTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 845 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954897-A | Bioconjugate and use thereof | 湖北大学 | 2025-05-09 | — | — | CN | claimed |
| US-12037472-B2 | Anaerobic composite matrix resins | TEXAS RESEARCH INTERNATIONAL, INC. (US) | 2024-07-16 | — | — | US | claimed |
| CN-117903008-A | Method for synthesizing oxynitride by using aniline | 东华理工大学 | 2024-04-19 | — | — | CN | claimed |
| CN-116768781-A | Method for synthesizing quaternary carbon o-diamine by photocatalysis | 大连理工大学 | 2023-09-19 | — | — | CN | claimed |
| US-11597735-B2 | Highly efficient free radical photopolymerizations through enabled dark cure | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2023-03-07 | — | — | US | claimed |
| US-20210395473-A1 | ANAEROBIC COMPOSITE MATRIX RESINS | TEXAS RESEARCH INTERNATIONAL, INC. (US) | 2021-12-23 | — | — | US | claimed |
| US-11084913-B2 | Anaerobic composite matrix resins | TEXAS RESEARCH INTERNATIONAL, INC. (US) | 2021-08-10 | — | — | US | claimed |
| US-20210163508-A1 | HIGHLY EFFICIENT FREE RADICAL PHOTOPOLYMERIZATIONS THROUGH ENABLED DARK CURE | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2021-06-03 | — | — | US | claimed |
| WO-2019151884-A1 | USE OF N,N-DIMETHYL-PARA-ANISIDINE AS AN INHIBITOR OF HYDROGEN SULFIDE CORROSION AND HYDROGEN EMBRITTLEMENT | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ИФОТОП " | 2019-08-08 | — | — | WO | claimed |
| WO-2019113602-A1 | HIGHLY EFFICIENT FREE RADICAL PHOTOPOLYMERIZATIONS THROUGH ENABLED DARK CURE | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2019-06-13 | — | — | WO | claimed |
| EP-0527156-A4 | HIGHLY CONDUCTIVE POLYMER THICK FILM COMPOSITIONS | — | 1993-05-26 | — | — | EP | claimed |
| EP-0527156-A1 | HIGHLY CONDUCTIVE POLYMER THICK FILM COMPOSITIONS. | ADVANCED PROD INC (US) | 1993-02-17 | — | — | EP | claimed |
| US-5141777-A | Blend of thermoplastic resin, tertiary amine and silver flakes | ADVANCED PRODUCTS, INC. (US) | 1992-08-25 | — | — | US | claimed |
| US-5089173-A | Thermpopastic polymers, a tertiary amine and conductive silver flake filler | ADVANCED PRODUCTS INC. (US) | 1992-02-18 | — | — | US | claimed |
| WO-1991017550-A1 | HIGHLY CONDUCTIVE POLYMER THICK FILM COMPOSITIONS | ADVANCED PRODUCTS, INC. (US) | 1991-11-14 | — | — | WO | claimed |
| US-4588583-A | ACRYLATES, ESTERS, BONE CEMENT | BEIERSDORF AKTIENGESELLSCHAFT (DE) | 1986-05-13 | — | — | US | claimed |
| EP-0051365-B1 | ANAEROBICALLY CURING COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-01-09 | — | — | EP | claimed |
| US-4373077-A | Anaerobically curing compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-02-08 | — | — | US | claimed |
| US-4370467-A | CYANATE, PEROXIDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1983-01-25 | — | — | US | claimed |
| EP-0051365-A1 | Anaerobically curing compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-05-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11597735-B2 | Highly efficient free radical photopolymerizations through enabled dark cure | PHF2, KDM3B, KDM2B | SLC2A1 4705/4885APP 3337/4885MAPT 4310/4885 |
| US-20210163508-A1 | HIGHLY EFFICIENT FREE RADICAL PHOTOPOLYMERIZATIONS THROUGH ENABLED DARK CURE | PHF2, KDM3B, KDM2B | SLC2A1 4705/4885APP 3337/4885MAPT 4310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.